Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark Bresnik, MD
Gilead Sciences
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
92 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Innsbruck, Austria
- Facility name not stated
Salzburg, Austria
- Facility name not stated
Antwerp, Belgium
- Facility name not stated
Brussels, Belgium
- Facility name not stated
Brussels, Belgium
- Facility name not stated
Ghent, Belgium
- Facility name not stated
Leuven, Belgium
- Facility name not stated
Copenhagen, Denmark
- Facility name not stated
Amiens, France
- Facility name not stated
Bordeaux, France
- Facility name not stated
Caen, France
- Facility name not stated
Créteil, France
- Facility name not stated
Lille, France
- Facility name not stated
Lisieux, France
- Facility name not stated
Montpellier, France
- Facility name not stated
Nice, France
- Facility name not stated
Paris, France
- Facility name not stated
Pessac, France
- Facility name not stated
Rennes, France
- Facility name not stated
Berlin, Germany
- Facility name not stated
Berlin, Germany
- Facility name not stated
Bochum, Germany
- Facility name not stated
Essen, Germany
- Facility name not stated
Essen, Germany
- Facility name not stated
Giessen, Germany
- Facility name not stated
Hamburg, Germany
- Facility name not stated
Leipzig, Germany
- Facility name not stated
Magdeburg, Germany
- Facility name not stated
Mainz, Germany
- Facility name not stated
München, Germany
- Facility name not stated
Dublin, Ireland
- Facility name not stated
Dublin, Ireland
- Facility name not stated
Dublin, Ireland
- Facility name not stated
Dublin, Ireland
- Facility name not stated
Galway, Ireland
- Facility name not stated
Ancona, Italy
- Facility name not stated
Catania, Italy
- Facility name not stated
Milan, Italy
- Facility name not stated
Naples, Italy
- Facility name not stated
Palermo, Italy
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2008
- Primary completion
- 31 May 2010
- Completion
- 30 Nov 2010
- Last update posted
- 4 Jul 2011
- Registered enrollment
- 274
- Registry id
- NCT00757237
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.